Versigent Q3 2026 Earnings: Adjusted EBITDA Margin Expands Despite 1% Adjusted Sales Growth

Versigent (NYSE: VGNT) reported Q3 2026 net sales of $2.450 billion, up 7.2% from $2.286 billion, while diluted EPS declined to $1.41 from $1.54. Non-GAAP adjusted EBITDA rose 10.9% and its margin expanded, but net income attributable to Versigent fell as interest expense from the company’s first-quarter debt financing weighed on GAAP results. Operating cash flow increased slightly, while higher launch-related capital spending reduced free cash flow.

Core Earnings Data

Reported sales growth substantially exceeded the company’s underlying growth measure. Adjusted net sales growth, which excludes commodity and foreign-currency movements, was approximately 1%, compared with the 7.2% increase in reported sales.

Operating income and adjusted EBITDA increased, but attributable net income declined to $102 million. Adjusted diluted EPS, a non-GAAP measure, was $1.91 for the quarter.

Adjusted EBITDA and free cash flow are non-GAAP measures. For periods before the April 1, 2026 spin-off, the company calculated EPS using the 70.89 million ordinary shares outstanding immediately after the spin-off.

Reported Sales Growth Outpaced Underlying Growth, While Interest Changed the Profit Picture

Versigent’s reconciliation indicates that commodity and foreign-currency movements accounted for roughly six percentage points of reported sales growth. Adjusted net sales growth was only about 1%, although the company achieved that increase while global automotive production was lower.

Profitability developed differently depending on the measure. Adjusted EBITDA margin expanded by 40 basis points as operational execution, favorable net pricing, and foreign-exchange effects more than offset higher commodity costs and the demands of numerous program launches.

GAAP earnings moved in the opposite direction because interest expense reached $36 million, compared with a negligible amount in Q3 2025. The expense primarily resulted from senior notes and a credit facility issued during the first quarter of 2026. Lower income tax expense of $35 million, down from $54 million, partly offset the new financing burden.

Profitability, Cash Flow, and the Balance Sheet

Net cash provided by operating activities was $225 million, up slightly year over year. Capital expenditures increased 25% to $55 million from $44 million as Versigent supported elevated launch activity, causing free cash flow to decline to $170 million despite the modest improvement in operating cash flow. Quarterly free cash flow also included $11 million of separation-related costs, compared with $7 million a year earlier.

Versigent ended September with $638 million in cash and cash equivalents, compared with $276 million at the end of 2025. The balance sheet also included $58 million of short-term debt and $2.066 billion of long-term debt, with the latter rising from $3 million at year-end following the first-quarter financing. For the first nine months of 2026, the company reported $2.063 billion of net proceeds from senior notes and its credit agreement, as well as a $1.894 billion cash distribution to its former parent.

The board declared a quarterly dividend of $0.13 per ordinary share, payable December 17, 2026, to shareholders of record on December 4.

Full-Year 2026 Guidance

Versigent raised the midpoint of its net sales range because of higher commodity pass-throughs and increased both the midpoint and upper end of its free cash flow outlook. The adjusted EBITDA midpoint remained unchanged, but the company narrowed the range around it.

Adjusted EBITDA and free cash flow guidance are forward-looking non-GAAP measures. Versigent did not provide GAAP reconciliations because management said projecting event-driven and non-core items was not practical and those items could be significant.

Management’s View

CEO Joseph Liotine emphasized that the company managed a high volume of complex launches across multiple manufacturing facilities despite lower global automotive production and macroeconomic volatility. Versigent also secured $2.1 billion of bookings during the quarter and continued investing in commercial and go-to-market capabilities for adjacent markets.

CFO Doug Ostermann linked the updated guidance to year-to-date results and the company’s current macroeconomic outlook. Management’s outlook therefore combines higher commodity-related reported sales with a narrower adjusted EBITDA range and improved expectations for cash generation.

Risks Investors Should Monitor

• Underlying sales growth remains modest: Adjusted net sales growth was approximately 1%, far below the 7.2% reported increase after excluding commodity and currency effects. Continued weakness in global automotive production could pressure demand.
• Commodity movements affect both sales and costs: Higher commodity pass-throughs lifted reported revenue and full-year sales guidance, but higher commodity costs also partly offset adjusted EBITDA gains.
• Debt financing is weighing on GAAP earnings: Quarterly interest expense rose to $36 million after the first-quarter financing, contributing to lower attributable net income despite improved operating income.
• Launch activity raises execution and cash-flow demands: Numerous complex launches were accompanied by higher capital expenditures, which reduced quarterly free cash flow even as operating cash flow increased slightly.

Summary

Versigent’s Q3 2026 results showed improved operating income and adjusted EBITDA margins despite only modest adjusted sales growth. Commodity and currency effects boosted reported revenue, while new interest expense caused GAAP net income and EPS to decline. The principal follow-up areas are underlying automotive demand, launch execution, financing costs, and whether the company delivers the higher full-year free cash flow range.